| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Common Stock | Options Exercise | $38,760 | +1,000 | +41% | $38.76 | 3,457 | 01 Mar 2022 | Direct | F1 |
| transaction | RGEN | Common Stock | Sale | $198,480 | -1,000 | -29% | $198.48 | 2,457 | 01 Mar 2022 | Direct | F2 |
| transaction | RGEN | Common Stock | Sale | $197,580 | -1,000 | -41% | $197.58 | 1,457 | 01 Mar 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Stock Option (Right to Buy) | Options Exercise | $0 | +1,000 | $0.000000* | 0 | 01 Mar 2022 | Common Stock | 1,000 | $38.76 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021. |
| F2 | $198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F3 | This option is currently exercisable. |